title: Effect of active immunization to luteinizing-hormone-releasing hormone on the fertility and histoarchitecture of the reproductive organs of male rat.
abstract: The feasibility of using a vaccine against luteinizing-hormone-releasing factor for suppression of pituitary and gonadal functions has been indicated for some time. Antibody production against this low-molecular-weight, naturally occurring decapeptide, however, requires to be coupled to a carrier protein to enhance its immunogenicity. LHRH was coupled to diphtheria toxoid (DT). Adult male Sprague-Dawley rats with a mean basal body weight of 200 g were immunized with anti-LHRH-DT (20 micrograms/injection/rat) at four-week intervals. An equal number of unexposed animals served as controls. Six animals were killed every two weeks up the end of the week 43. The vaccination schedule did not have any effect on the gain in body weight, nor was any adverse effect of vaccination observed in the course of the investigations. The pituitary, prostate, epididymis, testes, seminal vesicles, adrenal and thyroid were excised for determination of organ weight and histological examination. The adrenal, pituitary and thyroid showed no remarkable weight changes during the observation period, whereas the weights of the reproductive organs demonstrated significant reductions compared to those of the control group. The histopathology revealed marked to significant changes in the gonads and the accessory sex organs including the prostate. A progressive phase of regeneration of spermatogenesis was evident 98 days after vaccination. Total recovery of spermatogenesis was observed 300 days after vaccination. The mating studies showed the return of fertility 300 days after vaccination. The litters borne were normal. Prostate showed recovery after 154 days of vaccination. Our observations lend strong support to the hypothesis that anti-LHRH vaccine can be effectively used on the management of prostate carcinoma. If the vaccination is given together with a suitable dose of long-acting androgen, contained in an adequate delivery system, the regimen may be used for the regulation of male fertility.
authors.affiliation: Institute of Zoology, University of Salzburg, Austria.
authors.forename: E
authors.initials: E
authors.lastname: Rovan
authors.forename: E
authors.initials: E
authors.lastname: Fiebiger
authors.forename: N R
authors.initials: NR
authors.lastname: Kalla
authors.forename: G P
authors.initials: GP
authors.lastname: Talwar
authors.forename: W
authors.initials: W
authors.lastname: Aulitzky
authors.forename: J
authors.initials: J
authors.lastname: Frick
mesh_terms: D000818:Animals; D004168:Diphtheria Toxoid; D005298:Fertility / Q000502:physiology*; D005837:Genitalia, Male / Q000473:pathology*; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors / Q000276:immunology*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D014611:Vaccination; D014612:Vaccines
chemical_list: D004168:Diphtheria Toxoid; D014612:Vaccines; D007987:Gonadotropin-Releasing Hormone